Paper32318059
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation.
Bonifazi F and 7 others. Front Immunol, 2020. Cited by 138 papers, by iCite.
Cite this record
ConductScience Library. Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation. Papers, record 32318059. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32318059
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibrinolytic Agents | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Hepatic Veno-Occlusive Disease | Major topic |
| Polydeoxyribonucleotides | Major topic |
| Postoperative Complications | Major topic |
| Animals | |
| Humans | |
| Palliative Care | |
| Risk Factors | |
| Transplantation, Homologous |
Source PubMed
References123
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30176678 | EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version). | Ultraschall Med | 2017 | https://conductscience.org/library/papers/30176678 | PubMed |
| 2 | 25300869 | Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation. | Biol Blood Marrow Transplant | 2015 | https://conductscience.org/library/papers/25300869 | PubMed |
| 3 | 26367232 | Anicteric veno-occlusive disease after hematopoietic stem cell transplantation in children. | Bone Marrow Transplant | 2016 | https://conductscience.org/library/papers/26367232 | PubMed |
| 4 | 9808553 | Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. | Blood | 1998 | https://conductscience.org/library/papers/9808553 | PubMed |
| 5 | 29767845 | Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome. | Br J Haematol | 2018 | https://conductscience.org/library/papers/29767845 | PubMed |
| 6 | 29789625 | Clinical diagnosis of veno-occlusive disease using contrast enhanced ultrasound. | Bone Marrow Transplant | 2018 | https://conductscience.org/library/papers/29789625 | PubMed |
| 7 | 27956374 | Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation. | Turk J Haematol | 2017 | https://conductscience.org/library/papers/27956374 | PubMed |
| 8 | 22364685 | Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. | Lancet | 2012 | https://conductscience.org/library/papers/22364685 | PubMed |
| 9 | 29945939 | The use of defibrotide in blood and marrow transplantation. | Blood Adv | 2018 | https://conductscience.org/library/papers/29945939 | PubMed |
| 10 | 3754835 | Defibrotide therapy for thrombophlebitis--controlled clinical trial. | Haemostasis | 1986 | https://conductscience.org/library/papers/3754835 | PubMed |
| 11 | 8338943 | Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial. | Blood | 1993 | https://conductscience.org/library/papers/8338943 | PubMed |
| 12 | 30660772 | Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/30660772 | PubMed |
| 13 | 17241926 | Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation. | Biol Blood Marrow Transplant | 2007 | https://conductscience.org/library/papers/17241926 | PubMed |
| 14 | 2159315 | Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. | Br J Haematol | 1990 | https://conductscience.org/library/papers/2159315 | PubMed |
| 15 | 8110625 | Defibrotide versus heparin in the prevention of coronary reocclusion after thrombolysis in acute myocardial infarction. | Cardiovasc Drugs Ther | 1993 | https://conductscience.org/library/papers/8110625 | PubMed |
| 16 | 30266674 | Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/30266674 | PubMed |
| 17 | 10754451 | Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes. | Pharmacology | 2000 | https://conductscience.org/library/papers/10754451 | PubMed |
| 18 | 29928989 | Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant. | Biol Blood Marrow Transplant | 2018 | https://conductscience.org/library/papers/29928989 | PubMed |
| 19 | 23680861 | Defibrotide: properties and clinical use of an old/new drug. | Vascul Pharmacol | 2013 | https://conductscience.org/library/papers/23680861 | PubMed |
| 20 | 9625683 | Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial. | Ann Intern Med | 1998 | https://conductscience.org/library/papers/9625683 | PubMed |
Cited by87
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 138 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42606689 | Liver sinusoidal endothelial cells in liver diseases and hepatocellular carcinoma: molecular mechanisms, physiology, and therapies. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42606689 | PubMed |
| 42582157 | Diagnostic delay of veno-occlusive disease in a myelofibrosis patient with pre-transplant transjugular intrahepatic portosystemic shunt: a case report. | Front Oncol | 2026 | https://conductscience.org/library/papers/42582157 | PubMed |
| 42506094 | Evaluation of Prophylactic Defibrotide Use in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multicenter Retrospective Cohort Study. | J Pers Med | 2026 | https://conductscience.org/library/papers/42506094 | PubMed |
| 42482898 | Re-exploration of the pharmacotherapeutic strategy for drug-induced liver injury: a narrative review. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42482898 | PubMed |
| 42469395 | Incidence, clinical risk factors, and biomarkers of SOS/VOD following allogeneic HSCT in adults. A real-life study by the Spanish group of HSCT and cell therapy (GETH-TC). | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/42469395 | PubMed |
| 42460105 | Late-onset Anicteric Veno-occlusive Disease after Haploidentical HSCT: Diagnostic Challenges in the Setting of CMV Reactivation. | Mediterr J Hematol Infect Dis | 2026 | https://conductscience.org/library/papers/42460105 | PubMed |
| 42437161 | Hippo-YAP/TAZ Signaling in Hematological Malignancies: Molecular Mechanisms, Pathway Crosstalk and Therapeutic Potential. | Cancer Manag Res | 2026 | https://conductscience.org/library/papers/42437161 | PubMed |
| 42420446 | Non-genotoxic transplantation and in vivo selection through epitope editing. | Nature | 2026 | https://conductscience.org/library/papers/42420446 | PubMed |
| 42237408 | Chronic arsenic poisoning from a realgar-containing traditional medicine causing hepatic veno-occlusive disease and polyserositis: a case report. | J Med Case Rep | 2026 | https://conductscience.org/library/papers/42237408 | PubMed |
| 42187578 | Assessment of Risks and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Recipients Including Potentially Undiagnosed Cases-A Multicenter Canadian Study. | Curr Oncol | 2026 | https://conductscience.org/library/papers/42187578 | PubMed |
| 41928587 | Toward Next-Gen Cell Therapy for Pediatric Patients: Neonatal Hepatocytes Tolerate Electroporation-Mediated Gene Editing and Engraft in the Liver. | CRISPR J | 2026 | https://conductscience.org/library/papers/41928587 | PubMed |
| 41437821 | Lipid dysregulation after hematopoietic stem cell transplant. | Haematologica | 2026 | https://conductscience.org/library/papers/41437821 | PubMed |
| 41397861 | Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. | J Rheumatol | 2026 | https://conductscience.org/library/papers/41397861 | PubMed |
| 41091797 | Community perceptions and practices on hepatic veno-occlusive disease in Tigray, Ethiopia: An explorative study challenging the attribution to Ageratum conyzoides. | PLoS Negl Trop Dis | 2025 | https://conductscience.org/library/papers/41091797 | PubMed |
| 41035660 | Results From a UK Consensus via Delphi on Practical Considerations Surrounding Risk Assessment and Patient Monitoring for a Prompt Diagnosis of Severe Veno-Occlusive Disease (VOD) in Adults Post-HSCT. | EJHaem | 2025 | https://conductscience.org/library/papers/41035660 | PubMed |
| 40919202 | Rivaroxaban alleviates hepatic sinusoidal obstruction syndrome in mice by modulating the gut microbiota and inhibiting the PI3K/Akt signaling pathway. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40919202 | PubMed |
| 40261550 | Atypical features of hepatic veno-occlusive disease/sinusoidal obstruction syndrome after inotuzumab ozogamicin in adult patients with acute lymphoblastic leukemia. | Blood Res | 2025 | https://conductscience.org/library/papers/40261550 | PubMed |
| 40253530 | Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial. | Bone Marrow Transplant | 2025 | https://conductscience.org/library/papers/40253530 | PubMed |
| 40216867 | Liver quad culture chip as a model for radiation injury research. | Sci Rep | 2025 | https://conductscience.org/library/papers/40216867 | PubMed |
| 40190874 | Sinusoidal Obstruction Syndrome Post-allogeneic Transplantation: A Complex Multisystem Challenge. | Cureus | 2025 | https://conductscience.org/library/papers/40190874 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32318059
GET https://conductscience.org/api/papers/v1/32318059/references?page=2